SPL 0.00% 9.5¢ starpharma holdings limited

Ann: AGM - Chairman address and CEO presentation, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,274 Posts.
    lightbulb Created with Sketch. 451
    Yes, it's really all about relationships. If SPL and AZD can work together and grow in a way that is mutually beneficial, all well and good. But no company wants to pay through the nose for something they can get a lot cheaper - they have to be accountable to their own shareholders as well and justify the cost. And nobody wants to slap down big money to buy out a company, no matter how large the optionality, if the IP can easily be replicated by a competitor. So it's possible that they are testing the IP and slowing things down to consider all the options. At some point something is going to give, but the sooner SPL can get revenues through the door with their own products and grow a big cash pile the better!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.